Health

550 views

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Making New 52-Week Lows

On Thursday’s trading session, the stock price of Pharmacyte Biotech Inc (OTCMKTS:PMCB) dropped more than 8% and made...

337 views

What Is The Buzz Surrounding Therapy Cells Inc (OTCMKTS:TCEL)?

In yesterday’s trading session, the stock price of Therapy Cells Inc (OTCMKTS:TCEL) declined 50% to close the trading...

210 views

TapImmune Inc. (OTCMKTS:TPIV) Makes A Comeback

In yesterday’s trading session, the stock price of TapImmune Inc. (OTCMKTS:TPIV) made a comeback and recorded gains of...

173 views

Anavex Life Sciences Corp (OTCMKTS:AVXL) Updates On New Appointment To Scientific Advisory Board

Anavex Life Sciences Corp (OTCMKTS:AVXL) reported appointment of Dr. Harald Hampel, MA, MD, PhD, MSc, to its Scientific...

135 views

Anavex Life Sciences Corp (OTCMKTS:AVXL) Appoints Harald Hampel To Scientific Advisory Board

Anavex Life Sciences Corp (OTCMKTS:AVXL) appointed Harald Hampel, MD, PhD, MSc, MA, to its Scientific Advisory Board. An...

214 views

Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial of ‘SGX942’

A couple of weeks ago, Soligenix Inc (OTCBB:SNGX) reported that it completed patient enrollment as suggested by the...

143 views

Anavex Life Sciences Corp (OTCMKTS:AVXL) Cash Reserves Surges To $8 Million In 3Q2015

Anavex Life Sciences Corp (OTCMKTS:AVXL) a biopharmaceutical entity in clinical stage advancing Anavex 2-73 for treatment of Alzheimer’s...

112 views

TapImmune Inc. (OTCMKTS:TPIV) Moves One Step Forward With Phase 2 Trial Of Triple Negative Breast Cancer

TapImmune Inc. (OTCMKTS:TPIV) updated that Mayo Clinic obtained $13.3 million grant to cover the various costs related to...

211 views

Anavex Life Sciences Corp (OTCMKTS:AVXL) Becoming A Hope In Alzheimer’s Market

The biotech sector has remained a target of short sellers in last one month. However, there are some...

166 views

TapImmune Inc. (OTCMKTS:TPIV) Updates On Phase II Trial Targeting Triple Negative Breast Cancer

TapImmune Inc. (OTCMKTS:TPIV) stated that Mayo Clinic received a grant of $13.3 million to cover the costs of...